Jefferson Clinical Trial: Can a Cholesterol Drug Prevent Colon Cancer?
Tuesday, March 22, 2011 - 15:00
in Health & Medicine
Thomas Jefferson University is part of a pivotal, nationwide clinical trial to evaluate rosuvastatin as a treatment to reduce the risk of colon cancer.